May 1, 2011
Does Medtronic action signal a shift?
Medtronic caused a stir in February 2011 when it canceled several contracts with the 2 largest group purchasing organizations (GPOs), Novation and Premier. The big device company ended 5 Novation contracts worth $2 billion covering spinal implants, neurosurgery power tools, bone graft materials, and cardiac rhythm management products plus a Premier spine contract.
Free Daily News
- Infusion pumps deemed high-risk in FDA early alert
- Stem cell researchers tout potential for sickle cell disease cure
- Study: Stem cell therapy restores vision in LSCD patients
- AMSURG launches nationwide campaign to spotlight rising colon cancer rates, urges early screening
- AAAHC seeks stakeholder feedback on revised v44 standards to elevate patient-centered care
- Hospital’s anesthesia reforms slash carbon footprint, expenses
- Study: Shifting imaging to outpatient centers could save billions
- Report: Health system margins shrink as hospital revenue grows
- Study: Cataract surgery increases diabetic retinopathy progression
- FDA announces Class 1 endovascular system, anesthesia system recalls
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement